ALPS Medical Breakthroughs ETF
SBIO
26 hedge funds and large institutions have $16.1M invested in ALPS Medical Breakthroughs ETF in 2016 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 9 closing their positions.
1% more ownership
Funds ownership: 14.43% → 15.43% (+1%)
7% less funds holding
Funds holding: 28 → 26 (-2)
18% less capital invested
Capital invested by funds: $19.6M → $16.1M (-$3.45M)
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$1.53M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.47M |
| 3 |
Jane Street
New York
|
+$860K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$629K |
| 5 |
PFS
Prospera Financial Services
Dallas,
Texas
|
+$438K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.88M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$1.56M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$956K |
| 4 |
VF
Virtu Financial
New York
|
-$926K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$468K |
SBIO Hedge Fund Activity: Q4 2016 in Review
26 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q4 2016, worth a combined $16.1M — down 18% from $19.6M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of SBIO and 7 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 6 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $1.53M. The largest seller was Morgan Stanley, cutting an estimated $1.88M.
- 26 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q4 2016, down from 28 in Q3 2016.
- Funds reported $16.1M of ALPS Medical Breakthroughs ETF stock for Q4 2016, down 18% quarter-over-quarter.
- 7 funds opened new ALPS Medical Breakthroughs ETF positions in Q4 2016 and 9 closed out, a net change of -2 holders.
- The largest ALPS Medical Breakthroughs ETF buyer in Q4 2016 was Citadel Advisors, an estimated $1.53M added.
- The largest ALPS Medical Breakthroughs ETF seller in Q4 2016 was Morgan Stanley, an estimated $1.88M sold.
Based on aggregated 13F filings for Q4 2016.